Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti‐TNF‐alpha therapy for Crohn's disease
Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti‐TNF‐alpha (TNF‐α) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients re...
Gespeichert in:
Veröffentlicht in: | Inflammatory bowel diseases 2008-10, Vol.14 (10), p.1392-1398 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!